Latest Equities News

AssetOwl Ltd reports a cautious quarter marked by debt renegotiations with related parties, board changes, and a tight cash position as it seeks to revive shareholder value.

QX Resources reported steady progress on its Queensland gold and US lithium brine projects while managing modest cash reserves and exploration expenditure in the March 2025 quarter.

Toubani Resources has cemented a fiscal agreement with the State of Mali under the 2023 mining code, advancing its Kobada Gold Project toward a final investment decision. A strategic A$29 million placement led by A2MP Investments further strengthens the company’s development pathway.

Arcadia Minerals is gearing up for a significant drilling campaign at its Karibib Copper Gold Project while navigating a competitive funding process for the Swanson Tantalum Mine. Strategic partnerships remain central to the company’s growth plans amid cautious lithium market conditions.

Arcadia Minerals has obtained a $150,000 convertible loan facility to maintain working capital and advance development and joint ventures across its key mining projects in Namibia.

AXP Energy has completed a successful 60-day gas-to-power trial at its Pathfinder Field, delivering 1.5 MW of off-grid power and generating maiden natural gas revenue. The company is accelerating its expansion plans, backed by NASDAQ-listed BitFuFu, aiming to scale operations to 25 MW by year-end.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

Kalamazoo Resources Limited reported a challenging quarter with ongoing negative cash flows but plans a $0.8 million capital raise to sustain its exploration activities.

MPower Group has completed a pivotal equity conversion of its Narromine Renewable Energy Project, extinguishing $10.36 million in project funding and positioning itself for a $700,000 gain. The company also secured additional financing and advanced its renewable energy pipeline amid ongoing operational challenges.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.

McLaren Minerals Limited reported a challenging quarter with operating and investing cash outflows offset by a significant equity financing inflow, ending March 2025 with a modest cash balance and less than two quarters of funding runway.